Anti-c-Maf Antibody, clone 2D16 ZooMAb^® Rabbit Monoclonal

ZooMAb^® antibodies represent an entirely new generation of recombinant monoclonal antibodies. Each ZooMAb^® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb^® antibodies are reliably available and ready to ship when you need them.

Transcription factor Maf (UniProt: O75444; also known as Transcription factor Maf, Proto-oncogene c-Maf, V-maf musculoaponeurotic fibrosarcoma oncogene homolog) is encoded by the MAF gene (Gene ID: 4094) in human. The c-Maf transcription factor is part of the basic leucine zipper (bZIP) family of proteins, characterized by a basic leucine zipper (bZip) structure that facilitates dimerization and DNA-binding. It plays a pivotal role in cellular differentiation, development, and homeostasis. It forms a homodimer or a heterodimer with other bHLH-Zip transcription factors. c-Maf functions as both a transcriptional activator and repressor, depending on its binding partners and context. c-Maf is critical in processes such as lens formation, osteoblast differentiation, macrophage function, and insulin transcription in pancreatic β-cells. It binds to Maf recognition elements (MAREs) via its bZIP domain, regulating downstream genes. Mutations in c-MAF gene are linked to congenital cataracts, Ayme-Gripp syndrome, and Duane retraction syndrome, among other conditions. Additionally, c-MAF has been implicated in oncogenesis, particularly in multiple myeloma, through its role in dysregulated gene expression pathways. Its activity is modulated by phosphorylation and interactions with other transcription factors, such as MYB, affecting immunity and apoptosis in T cells. This ZooMAb^® recombinant monoclonal antibody, generated by our proprietary technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Takahashi S., (2021), Exp Anim., 70(3):264-271).

We are committed to bringing you greener alternative products, which adhere to one or more of the 12 Principles of Green Chemistry. This antibody is preservative-free, produced without the harm or sacrifice of animals and exceptionally stable to allow for ambient shipping and storage if needed, and thus aligns with "Waste Prevention", "Designing Safer Chemicals" and "Design for Energy Efficiency". Click here for more information.

KLH-conjugated linear peptide corresponding to 20 amino acids from the C-terminal region of human c-Maf.

Quality Control Testing

Evaluated by Western Blotting in RPMI 8226 cell lysate.

Western Blotting Analysis: A 1:1,000 dilution of this antibody detected c-Maf in RPMI 8226 cell lysate.

Tested Applications

Affinity Binding Assay: A representative lot of this antibody bound with c-Maf peptide with at least one thousand-fold (1,000X) higher affinity than with non-specific control peptide.

Immunoprecipitation Analysis: 2 µg from a representative lot immunoprecipitated c-Maf from RPMI 8226 cell lysate.

Note: Actual optimal working dilutions must be determined by end user as specimens and experimental conditions may vary with the end user.

Clone 2D16 is a ZooMAb^® rabbit recombinant monoclonal antibody that detects c-Maf. It targets an epitope within 20 amino acids from the C-terminal region.

Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 µL.

300 µg/mL after reconstitution at 25 µL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 µL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.